- Home
- VALN vs ITIC Comparison
VALN vs ITIC Comparison
Compare VALN & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- ITIC
- Stock Information
- Founded
- VALN 2012
- ITIC 1972
- Country
- VALN France
- ITIC United States
- Employees
- VALN N/A
- ITIC N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- ITIC Specialty Insurers
- Sector
- VALN Health Care
- ITIC Finance
- Exchange
- VALN Nasdaq
- ITIC Nasdaq
- Market Cap
- VALN 488.9M
- ITIC 425.1M
- IPO Year
- VALN 2021
- ITIC N/A
- Fundamental
- Price
- VALN $4.66
- ITIC $271.60
- Analyst Decision
- VALN Strong Buy
- ITIC
- Analyst Count
- VALN 2
- ITIC 0
- Target Price
- VALN $18.50
- ITIC N/A
- AVG Volume (30 Days)
- VALN 22.7K
- ITIC 17.2K
- Earning Date
- VALN 11-07-2024
- ITIC 11-05-2024
- Dividend Yield
- VALN N/A
- ITIC 0.68%
- EPS Growth
- VALN N/A
- ITIC 22.45
- EPS
- VALN N/A
- ITIC 15.10
- Revenue
- VALN $176,817,979.00
- ITIC $241,018,000.00
- Revenue This Year
- VALN $24.30
- ITIC N/A
- Revenue Next Year
- VALN $16.05
- ITIC N/A
- P/E Ratio
- VALN N/A
- ITIC $17.99
- Revenue Growth
- VALN N/A
- ITIC 1.93
- 52 Week Low
- VALN $4.60
- ITIC $141.41
- 52 Week High
- VALN $12.85
- ITIC $283.27
- Technical
- Relative Strength Index (RSI)
- VALN 26.32
- ITIC 69.40
- Support Level
- VALN $4.63
- ITIC $225.73
- Resistance Level
- VALN $5.28
- ITIC $283.27
- Average True Range (ATR)
- VALN 0.18
- ITIC 7.09
- MACD
- VALN -0.09
- ITIC 3.59
- Stochastic Oscillator
- VALN 4.05
- ITIC 79.72
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
About ITIC Investors Title Company
Investors Title Co operates primarily in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment primarily issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.